BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,204,988 | -17.2% | 137,917 | -0.0% | 0.04% | -13.7% |
| Q2 2023 | $6,285,549 | +12.6% | 137,962 | +0.2% | 0.05% | +2.0% |
| Q1 2023 | $5,582,922 | -20.2% | 137,646 | +0.3% | 0.05% | -26.5% |
| Q4 2022 | $6,994,103 | -5.1% | 137,220 | +0.3% | 0.07% | -10.5% |
| Q3 2022 | $7,372,000 | -16.7% | 136,872 | -0.7% | 0.08% | -11.6% |
| Q2 2022 | $8,851,000 | -16.9% | 137,802 | +0.3% | 0.09% | 0.0% |
| Q1 2022 | $10,653,000 | -9.4% | 137,390 | +0.3% | 0.09% | -4.4% |
| Q4 2021 | $11,753,000 | +4.2% | 136,915 | -2.4% | 0.09% | -2.2% |
| Q3 2021 | $11,278,000 | -1.0% | 140,226 | -0.9% | 0.09% | -1.1% |
| Q2 2021 | $11,392,000 | -6.2% | 141,518 | -1.7% | 0.09% | -12.3% |
| Q1 2021 | $12,141,000 | +3.6% | 143,951 | -1.4% | 0.11% | 0.0% |
| Q4 2020 | $11,720,000 | -5.8% | 146,057 | -5.6% | 0.11% | -14.5% |
| Q3 2020 | $12,445,000 | +20.5% | 154,749 | +29.0% | 0.12% | -15.1% |
| Q2 2020 | $10,326,000 | -25.7% | 119,933 | -29.9% | 0.15% | -38.9% |
| Q1 2020 | $13,897,000 | +6.1% | 171,165 | +9.3% | 0.24% | +51.3% |
| Q4 2019 | $13,094,000 | +2.2% | 156,592 | +6.9% | 0.16% | +1.3% |
| Q3 2019 | $12,814,000 | +8.3% | 146,497 | +1.4% | 0.16% | +13.9% |
| Q2 2019 | $11,836,000 | -16.0% | 144,519 | -16.6% | 0.14% | -18.5% |
| Q1 2019 | $14,086,000 | +15.8% | 173,240 | -6.2% | 0.17% | +7.7% |
| Q4 2018 | $12,159,000 | -24.2% | 184,726 | -11.2% | 0.16% | +3.3% |
| Q3 2018 | $16,044,000 | +5.2% | 208,126 | +0.8% | 0.15% | -1.3% |
| Q2 2018 | $15,246,000 | -5.2% | 206,474 | -16.5% | 0.15% | -5.6% |
| Q1 2018 | $16,080,000 | -6.7% | 247,234 | -7.3% | 0.16% | -3.6% |
| Q4 2017 | $17,242,000 | +8.0% | 266,734 | +4.8% | 0.17% | -12.0% |
| Q3 2017 | $15,972,000 | +48.5% | 254,538 | +43.3% | 0.19% | +28.2% |
| Q2 2017 | $10,753,000 | +12.3% | 177,612 | -3.8% | 0.15% | +10.4% |
| Q1 2017 | $9,579,000 | +16.5% | 184,712 | -0.4% | 0.14% | +11.6% |
| Q4 2016 | $8,221,000 | -6.6% | 185,412 | +0.3% | 0.12% | -9.7% |
| Q3 2016 | $8,802,000 | -2.5% | 184,912 | -7.4% | 0.13% | +5.5% |
| Q2 2016 | $9,026,000 | +0.8% | 199,612 | -8.4% | 0.13% | +8.5% |
| Q1 2016 | $8,952,000 | +9.7% | 217,912 | +1.9% | 0.12% | +7.3% |
| Q4 2015 | $8,161,000 | -11.9% | 213,912 | -24.2% | 0.11% | -16.2% |
| Q3 2015 | $9,268,000 | -50.9% | 282,126 | +9.5% | 0.13% | -41.4% |
| Q4 2014 | $18,885,000 | +9.6% | 257,688 | +7.3% | 0.22% | +3.7% |
| Q3 2014 | $17,238,000 | -3.0% | 240,188 | -2.3% | 0.21% | -0.5% |
| Q2 2014 | $17,777,000 | -0.6% | 245,888 | +1.2% | 0.22% | -4.9% |
| Q1 2014 | $17,879,000 | +1.4% | 242,988 | -4.2% | 0.23% | +4.1% |
| Q4 2013 | $17,637,000 | -0.7% | 253,588 | -6.2% | 0.22% | -4.4% |
| Q3 2013 | $17,755,000 | -5.7% | 270,288 | -0.6% | 0.23% | -11.7% |
| Q2 2013 | $18,833,000 | -5.0% | 271,888 | -0.4% | 0.26% | -9.5% |
| Q1 2013 | $19,829,000 | – | 272,988 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |